10QSB 1 j1082_10qsb.htm 10QSB Prepared by MerrillDirect


U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-QSB

(Mark One)

ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended             June 30, 2001             

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________________ to _________________________

Commission file number  1-4530  

ASTREX, INC.
(Exact name of small business issuer as specified in its charter)

Delaware 13-1930803
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)  
   
205 Express Street,     Plainview, New York      11803
(Address of principal executive offices)
 
(516) 433-1700
(Issuer’s telephone number, including area code)




(Former name, former address and former fiscal year, if changed since last report)

 


Check  whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes 
ý  No  o


APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date.  As of July 30, 2001 common shares outstanding were  5,531,277 (does not include Convertible Preferred Stock).



 

ASTREX, INC.
       
INDEX

 

   
   
PART I:     Financial Information
   
Item 1.  Financial Statements:
   
  Consolidated Balance Sheets
  June 30, 2001 (unaudited) and March 31, 2001
   
  Consolidated Statements of Income (unaudited)
  Three months ended June 30, 2001 and 2000
   
  Consolidated Statements of Cash Flows (unaudited)
  Three months ended June 30, 2001 and 2000
   
  Notes to Consolidated Financial Statements (unaudited)
   
Item 2.  Management's Discussion and Analysis or Plan of Operations
   
   
PART II:    Other Information
   
Other Information and Signatures
   

 

 

 

PART I - Financial Information

ASTREX, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS

  June 30, 2001   March 31, 2001  
  (Unaudited)      
 
 
 
  (000's) Omitted  
Current Assets:        
  Cash and cash equivalents $ 27   $ 11  
         
  Accounts receivable (net of allowance
for doubtful accounts of $87 at June 30, 2001
and $79 at March 31, 2001)
       
       
2,568   2,451  
         
  Inventory 5,185   5,310  
           
  Prepaid expenses and other current assets 194   61  
  Deferred tax asset 200   200  
 
 
 
         
  Total current assets 8,174   8,033  
         
Property, plant and equipment at cost (net of
accumulated depreciation of $634 at June 30,
2001 and $618 at March 31, 2001)
       
       
695   701  
Other long-term assets 93   88  
 
 
 
         
Total Assets $ 8,962   $ 8,822  
 

 

 
         
Current Liabilities:        
  Accounts payable 1,521   1,567  
  Accrued liabilities 617   794  
 
 
 
         
  Total current liabilities 2,138   2,361  
 
 
 
         
  Long-term debt 2,180   2,000  
         
         
Shareholders' Equity:        
  Preferred Stock, Series A - issued, none -   -  
  Convertible Preferred Stock, Series B - $.01 par value;
authorized, 10,000,000; 1,897,381 shares issued
and outstanding at June 30, 2001 and March 31, 2001
(liquidation preference of $.25 a share)
       
       
       
19   19  
  Common Stock - par value $.01 par value; authorized,
15,000,000 shares; issued, 6,605,363 at June 30, 2001
and at March 31,2001
       
       
66   66  
  Additional paid-in capital 3,928   3,928  
  Retained earnings 952   767  
  Deferred compensation (8 ) (11 )
  Treasury stock, at cost (1,074,086 shares at June 30, 2001
and 1,059,086 shares at March 31, 2001)
       
(313 ) (308 )
 
 
 
         
  Total shareholders' equity 4,644   4,461  
 
 
 
         
Total liabilities and shareholders' equity $ 8,962   $ 8,822  
 
 
 


See accompanying notes to unaudited consolidated financial statements.

 

  ASTREX, INC. AND SUBSIDIARIES
  CONSOLIDATED STATEMENTS OF INCOME
  (Unaudited)

 

         
  THREE MONTHS ENDED  
   
  JUNE 30,  
  2001   2000  
 
 
  (000's) Omitted  
         
Net sales $ 5,157   $ 4,567  
Cost of sales 3,974   3,542  
 
 
 
  Gross profit 1,183   1,025  
         
Selling, general and        
administrative expenses 954   829  
 
 
 
  Income from operations 229   196  
         
Interest expense 39   43  
 
 
 
  Income before provision        
  for income taxes 190   153  
         
Provision for income taxes 6   0  
 
 
 
  Net income $ 184   $ 153  
 
 
 
         
         
Per share data for the three months ended June 30, 2001 and 2000 are as follows:        
         
Weighted average common shares and        
common equivalent shares outstanding:        
  Basic 5,471,552   5,626,777  
   
 
 
  Diluted 7,433,933   5,628,206  
 
 
 
Net income per share:        
  Basic $ 0.03   $ 0.03  
   
 
 
  Diluted $ 0.02   $ 0.03  
 
 
 

 

See accompanying notes to unaudited consolidated financial statements.  

 

 

ASTREX, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

 

  FOR THE THREE MONTHS ENDED JUNE 30,  
  2001   2000  
 
 
  (000's) Omitted  
         
Cash Flows From Operating Activities:        
         
  Net income $ 184   $ 153  
         
  Adjustments to reconcile net income to net        
  cash (used in) operating activities:        
  Depreciation and amortization 16   24  
  Amortization of deferred stock compensation 4   -  
  Changes in assets and liabilities:        
  (Increase)/decrease in accounts receivable, net (117 ) 274  
  Increase in prepaid expenses and other current assets (133 ) (111 )
  Decrease in inventory 125   49  
  Increase in non-current assets (8 ) -  
  Decrease in accounts payable (46 ) (370 )
  Decrease in accrued liabilities (177 ) (56 )
 
 
 
Net cash (used in) operating activities (152 ) (37 )
         
Cash flows used in investing activities:        
  Capital expenditures (10 ) (9 )
 
 
 
Net cash (used in) investing activities (10 ) (9 )
 
 
 
Cash flows from financing activities:        
  Purchase of Treasury Stock (5 ) -  
  Deferred financing costs 3   3  
  Principal payments under capital lease obligations -   (12 )
  Proceeds from loans payable, net 180   -  
 
 
 
Net cash  provided by/(used in) financing activities 178   (9 )
 
 
 
         
Net change in cash and cash equivalents 16   (55 )
         
Cash and cash equivalents - beginning of period 11   57  
 
 
 
Cash and cash equivalents - end of period $ 27   $ 2  
 
 
 

 

See accompanying notes to unaudited consolidated financial statements.  

 

 

 

ASTREX, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE A - UNAUDITED FINANCIAL STATEMENTS

The consolidated balance sheet as of June 30, 2001 and the consolidated statements of income and the statement of cash flows for the three months ended June 30, 2001 and 2000 and the statement of cash flows for the three months ended June 30, 2001 and 2000, have been prepared by the Company without audit.  In the opinion of management, all adjustments (which include only normally recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at June 30, 2001 (and for all periods presented) have been made.

Certain information and note disclosures, normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America, have been condensed or omitted.  It is suggested that these consolidated financial statements be read in conjunction with the financial statements and notes thereto included in the Annual Report on Form 10-KSB for the year ended March 31, 2001 filed by the Company.  The results of operations for the periods ended June 31, 2001 and 2000 are not necessarily indicative of the operating results for the respective full years.

NOTE B – EARNINGS PER COMMON SHARE

The following table sets forth the reconciliation of the weighted average number of common shares:

  Three months ended  
  June 30,  
     
  2001   2000  
  (Unaudited)   (Unaudited)  
 
 
 
         
Basic 5,471,552   5,626,777  
Effect of Series B Convertible
Preferred Stock
1,897,381      
Effect of dilutive securities (non-
vested restricted stock)
65,000   1,429  
 
 
 
Diluted 7,433,933   5,628,206  
 
 
 

 

NOTE C  - SHAREHOLDERS’ EQUITY

During the first quarter of fiscal year ended March 31, 2002, the Company purchased 15,000 shares of its stock on the open market.  These shares were recorded as treasury stock at their aggregate cost of approximately $5,000.  In fiscal year ended March 31, 2001, the Company purchased 145,500 shares of its common stock for $43,042 on the open market.  These shares are being held as treasury shares.

ASTREX, INC. AND SUBSIDIARIES
MANAGEMENT'S DISCUSSION AND ANALYSIS
OR PLAN OF OPERATIONS

RESULTS OF OPERATIONS

             Net income for the three months ended June 30, 2001 was approximately $184,000, an increase of $31,000 or 20% from the same three month period last fiscal year.  This increase is principally the result of higher sales volume.

             Sales increased by approximately $590,000 or 13%, for the three months ended June 30, 2001, from the comparable three month period in 2000. To a significant extent "Sales" reflect shipping of past confirmed orders (i.e. "backlog") as opposed to placement of orders during the quarter (i.e. "bookings"). During the quarter ended June 30, 2001 backlog increased approximately 7% with confirmed but unshipped orders at June 30, 2001 of approximately $4,496,000 as compared to approximately $4,220,000 at June 30, 2000. Bookings for the quarter ended June 30, 2001 were basically even as compared to the comparable quarter in 2000, $4,679,000 compared to $4,721,000, but with some slippage toward the end of the quarter ended June 30, 2001 which has continued into the quarter ended September 30, 2001.

             The Company’s gross margin remained relatively constant at 22.9% for three months ended June 30, 2001 as compared to 22.4% for the same period last fiscal year.

             Selling, general and administrative expenses increased by approximately $125,000, or 15%, for the three months ended June 30, 2001 from the comparable previous three month period in 2000. This increase was primarily the result of advertising, salary, bonus, commission and employee benefit related expenses.

             Interest expense decreased by approximately $4,000 for the three months ended June 30, 2001, from the previous comparable three month period in 2000 due to a reduction in interest rates.

             The provision for income taxes for the three months ended June 30, 2001 consists principally of state and local taxes. The Company did not record a provision for income tax expense for the three months ended June 30, 2000 based on the recognition of certain tax benefits available to the Company.

ASTREX, INC. AND SUBSIDIARIES
MANAGEMENT'S DISCUSSION AND ANALYSIS
OR PLAN OF OPERATIONS

LIQUIDITY AND CAPITAL RESOURCES

The Company utilized approximately $152,000 in cash from its operating activities for the three months ended June 30, 2001.  At June 30, 2001, the Company had working capital of $6,036,000 and its stockholders’ equity was $4,644,000.  The Company believes that its present working capital, cash generated from operations and amounts available under the loan agreement will be sufficient to meet its cash needs during the next year. The Company's principal credit facility is a line of credit and a term loan from the same bank lender (“Line”).  The Line is secured by substantially all of the Company's assets including a mortgage on the 205 Express Street property.  The term of the Line runs to April 30, 2002.  Borrowings under the line of credit portion of the Line, are based on the Company’s inventory and receivables. On June 30, 2001, the Company owed $2,180,000 on the Line. The Company’s relationship with its secured lender is satisfactory and the Company believes that the lending arrangement will be adequate for the foreseeable future.

 

CAUTIONARY LANGUAGE REGUARDING FORWARD LOOKING STATEMENTS

When used herein, the words “believe,” “anticipate,” “think,” “intend,” “will be,” “expect” and similar expressions identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act  of 1995.  Such statements are not guarantees of future performance and involve certain risks and uncertainties discussed herein, which could cause actual results to differ materially from those in the forward-looking statements.  Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date hereof.  Readers are also urged carefully to review and consider the various disclosures made by the Company which attempt to advise interested parties of the factors which affect the Company’s business, including, without limitation, the disclosures made in the Company’s Annual Report on Form 10-KSB for the fiscal year ended March 31, 2001 under the caption “Management’s Discussion and Analysis of Financial Condition and Results of  Operation.”

PART II - OTHER INFORMATION

Item 2.  Changes in Securities.

             none

Item 4.  Submission of Matters to a Vote of Security Holders.

             none

 

Item 5.  Other Information

In the three months ended June 30, 2001, the Company purchased 15,000 shares of its stock  on the open market.  These shares were recorded as treasury stock at their aggregate cost of approximately $5,000.

Item 6.   Exhibits and Reports on Form 8–K.

             none

 

(A)         Exhibits

Exhibit Description Previously Filed and Incorporated by reference or Filed Herewith

3 (a) Certificate of Incorporation of Astrex, Inc., as amended (a Delaware corporation) Filed as Exhibit 3(a) to the Form 10-QSB of the Company for the quarter ended September 30, 1997

3 (b) By-Laws of Astrex, Inc., as amended Filed as Exhibit 3(b) to the Form 10-QSB of the Company for the quarter ended September 30, 1996

4 Astrex, Inc. Certificate of Designations, Preferences and Rights of Series B Convertible Preferred Stock Filed as Exhibit 4 to the Form 10-QSB of the Company for the quarter ended June 30, 2000

 

(B)        Reports on Form 8-K:

             None

SIGNATURES

In accordance with the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf, thereunto duly authorized.

  ASTREX, INC.
   
Date:  August 10, 2001 By: s/ Michael McGuire
  Michael McGuire
  Director, President and
  Chief Executive Officer
   
   
  CHIEF FINANCIAL OFFICER
  OF ASTREX, INC.
   
Date:  August 10, 2001 By: s/ Lori A. Sarnataro
  Lori A. Sarnataro
  Chief Financial Officer, Executive Vice
President, Treasurer, and Secretary